ANTIHYPERTENSIVE THERAPY AND THE RISK OF CORONARY HEART-DISEASE

被引：0

作者：

AMES, RP

HILL, P

机构：

[1] COLUMBIA UNIV COLL PHYS & SURG,NEW YORK,NY 10032

[2] ST LUKES ROOSEVELT HOSP,NEW YORK,NY

来源：

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 1982年 / 4卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S206 / S212

页数：7

共 50 条

[1] ANTIHYPERTENSIVE DRUG-THERAPY AND CORONARY HEART-DISEASE RISK
SCHOENBERGER, JA
[J]. JOURNAL OF FAMILY PRACTICE, 1993, 36 (01): : 70 - 84
[2] PREDICTED REDUCTIONS IN THE RISK OF CORONARY HEART-DISEASE BY ANTIHYPERTENSIVE THERAPY - THE CONFOUNDING EFFECT OF LIPIDS
HANSSON, L
[J]. JOURNAL OF HYPERTENSION, 1990, 8 : S13 - S16
[3] RISK-FACTORS FOR CORONARY HEART-DISEASE - SELECTING APPROPRIATE ANTIHYPERTENSIVE THERAPY - INTRODUCTION
SEVER, PS
REID, JL
[J]. JOURNAL OF HUMAN HYPERTENSION, 1990, 4 : 1 - 1
[4] LIPIDS, LIPOPROTEINS, AND CORONARY HEART-DISEASE - IMPLICATIONS FOR ANTIHYPERTENSIVE THERAPY
FEHER, MD
BETTERIDGE, DJ
[J]. CARDIOVASCULAR DRUGS AND THERAPY, 1989, 3 : 333 - 340
[5] CLINICAL IMPLICATION OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH CORONARY HEART-DISEASE
FRANZ, IW
PAEPRER, H
SCHMUTZLER, H
[J]. HERZ KREISLAUF, 1986, 18 (09): : 443 - 447
[6] ANTIHYPERTENSIVE DRUGS AND CORONARY HEART-DISEASE
MOSER, M
[J]. LANCET, 1980, 2 (8197): : 745 - 745
[7] IMPLICATIONS OF DOXAZOSIN THERAPY ON RISK OF CORONARY HEART-DISEASE
HANSSON, L
[J]. AMERICAN HEART JOURNAL, 1988, 116 (06) : 1832 - 1837
[8] CORONARY HEART-DISEASE - POSSIBLE RISK IN MEGAVOLTAGE THERAPY
RASMUSSEN, S
DOSSING, M
WALBOMJORGENSEN, S
[J]. ACTA MEDICA SCANDINAVICA, 1978, 203 (03): : 237 - 239
[9] THERAPY OF CORONARY HEART-DISEASE
KUBLER, W
[J]. MEDIZINISCHE WELT, 1977, 28 (14): : 663 - 668
[10] CORONARY HEART-DISEASE RISK-FACTORS AND ANTIHYPERTENSIVE DRUG SELECTION - SUMMARY
KAPLAN, NM
[J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1982, 4 : S265 - S265

← 1 2 3 4 5 →